OncologySTAT Marks One-Year Anniversary with Expert Physician Commentaries
on Recent Cancer Research and Practice Developments Expert Physician Panel Selects Biomarker-Directed, Individualized Cancer
Treatment as Year's Most Influential Oncology Development
NEW YORK, Sept. 9 /PRNewswire/ -- OncologySTAT (http://www.OncologySTAT.com), a free web site featuring high-quality, scientifically based research and cancer care information for oncologists and other healthcare professionals, today celebrated its one-year anniversary by releasing a list of the most influential oncology developments of the past year chosen by an expert physician panel. Two overriding themes of this unique online editorial feature (http://www.oncologystat.com/home/Editors_Corner/1_Year_Anniversary.html) are biomarker-directed treatment decisions and the growing clinical role of personalized medicine.
OncologySTAT's expert panel includes 12 of the most influential names in hematology and oncology, including two past-presidents of the American Society of Clinical Oncology (ASCO). Based on their expertise and experience, this distinguished group identified the developments with the greatest potential for shaping the future direction of oncology.
"The story of biomarkers reverberates across various tumor types and offers a new paradigm for cancer treatment," says Lee Schwartzberg, M.D., F.A.C.P., OncologySTAT's Editor-in-Chief. "Cancer care professionals will benefit from a review of this and other top cancer developments generated collaboratively by OncologySTAT's panel of the world's leading oncologists and made accessible through links to original research and expert commentary on OncologySTAT."
The advisors' top story choices reflect a trend toward tumor subtype
analysis and treatments
Copyright©2008 PR Newswire.
All rights reserved